ʻO Iulai 28 ka 13th World Hepatitis Day.I kēia makahiki, ʻo ke poʻomanaʻo o ka hoʻolaha ʻana o Kina ʻo "E hoʻomau i ka pale ʻana mua, hoʻoikaika i ka ʻike a me ka ʻike ʻana, a me ka hoʻomaʻamaʻa ʻana i ka Antiviral Treatment".

Loaʻa i ka ate nā hana metabolic, detoxifying, hematopoietic a me ka immune, a he hopena koʻikoʻi i ke olakino holoʻokoʻa.Eia nō naʻe, ʻaʻohe mau hōʻailona ʻike ʻia ka maʻi hepatitis viral a hiki i ka piʻi ʻana o ka maʻi i kahi pae kiʻekiʻe.

Wahi a ka World Health Organization (WHO), he 10% wale nō o ka poʻe i maʻi i ʻike i ko lākou maʻi, a he 22% wale nō o ka poʻe i maʻi i loaʻa i ka lāʻau lapaʻau.Ma waena o ka poʻe i loaʻa i ka maʻi hepatitis C, ʻoi aku ka kiʻekiʻe o ka hapa o ka poʻe ʻike ʻole a mālama ʻole ʻia.No laila, he mea koʻikoʻi ka mālama ʻana i ke olakino o ke akepaʻa no ke olakino kanaka.

ʻO Polofesa Lin Zhibin o ka Hale Hōʻikeʻike Ola Ola o Peking University:ʻO Reishi mushroomhe hopena koʻikoʻi ka pale ʻana i ka ate.

Ua haʻi ʻo Polofesa Lin Zhibin i ka maikaʻi o Reishi mushroom i ka maʻi hepa ma kāna mau ʻatikala a hana i nā manawa he nui:

● Mai ka 1970s, ua hōʻike ʻia nā hōʻike lapaʻau he nuiʻO Reishi mushroomʻO ka hoʻomākaukau ʻana he 73% a hiki i 97% i ka mālama ʻana i ka maʻi hepatitis, me ka nui o ka hoʻōla maʻi mai 44% a 76.5%.

Ua hōʻike ʻia ʻo Reishi mushroom i ka maikaʻi o ka mālama ʻana i ka maʻi hepatitis ma kāna iho, a hiki nō hoʻi ke hoʻonui i ka maikaʻi o nā lāʻau antiviral i ka mālama ʻana i ka maʻi hepatitis mau loa.

Ma 10 mau hōʻike i paʻi ʻia e pili ana i ka noiʻi ʻana i ka maʻi hepatitis viral, ua hōʻike ʻia ma kahi o 500 mau hihiaReishiua hoʻohana wale ʻia a i hui pū ʻia me nā lāʻau antiviral no ka mālama ʻana i ka maʻi hepatitis viral.Hōʻike ʻia kona hopena therapeutic e like me kēia:

(1) Hoʻemi ʻia a nalowale paha nā hōʻailona kumuhana e like me ka luhi, ka pau ʻana o ka ʻai, ka ʻōpū o ka ʻōpū, a me ka ʻeha o ka ate;

(2) Hoʻi ka pae o ka serum ALT i ka maʻamau a i ʻole ke emi ʻana;

(3) Hoʻi ka ate a me ka spleen i ka mea maʻamau a i ʻole ka emi ʻana i nā pae like ʻole.

—Weheia mai ka pp. 95-102 oLingzhiFmai Mmea huna To ʻepekemana Lin Zhibin

Ua kuhikuhi ʻo Polofesa Lin Zhibin i kāna mau haʻiʻōlelo he hopena maikaʻi ʻo Reishi i ka pale ʻana i ka ate i ka hana lapaʻau.

ʻO ka hopena pale o Reishi e pili pū ana me nā wehewehe ʻana i nā kikokikona lapaʻau Kina kahiko o Reishi hiki ke hoʻohui i ka ate qi a hoʻonui i ka spleen qi.

Ua hōʻoia ka noiʻiReishihiki ke hoʻomaikaʻi maikaʻi i ke kūlana o nā maʻi me ka maʻi hepatitis.

Ma Malaki 2020, ua paʻi ʻia kahi haʻawina maCytokinee nā mea noiʻi mai Inner Mongolia University, Inner Mongolia Academy of Agricultural and Animal Husbandry Sciences, a me Toyama University i ʻikeʻO Ganoderma lucidumʻO ka ethanol extract, a me kāna triterpene compound ganodermanontriol, hiki ke kāohi i ka mumū i hana ʻia e ka lipopolysaccharide (LPS), kahi mea nui o ka membrane waho bacteria, in vitro.

I loko o kahi noiʻi kahi i hoʻopaʻa ʻia ai nā ʻiole me ka maʻi hepatitis fulminant me ka ganodermanontriol, ua hōʻike ʻia ka nānā ʻana o ko lākou mau ate he 6 mau hola ma hope mai:

① ʻO nā pae o ka maʻi hepatitis e hōʻike i ka AST (aspartate aminotransferase) a me ka ALT (alanine aminotransferase) i loko o ke koko o nā ʻiole.Reishiua emi loa ka hui;

② Ua ho'ēmi nuiʻia nā manaʻo o TNF-α (tumor necrosis factor-alpha) a me IL-6 (interleukin-6),ʻelua o nā mea nui pro-inflammatory i loko o ke ake;

③ Ua hōʻike ʻia ka nānā ʻana i nā ʻāpana ʻiʻo o nā ʻiole, ma lalo o ka pale o ganodermanontriol, ʻoi aku ka liʻiliʻi o ka necrosis o ka ate.

Hōʻike nā hopena noiʻiʻO Ganoderma lucidumhiki ke hāʻawi i ka palekana nui i ka ʻeha o ke ake i hoʻokumu ʻia e ka ʻeha nui.

Ua hōʻoia ka noiʻi maʻi e hiki iā Reishi ke hoʻomaikaʻi i ke ʻano o ka maʻi hepatitis mau loa.

Ua hōʻike ʻia ka noiʻi lāʻau lapaʻau e ka Second Clinical Medical College o Guangzhou University of Traditional Chinese Medicine i nā maʻi hepatitis B i lawe.Ganodermalucidumcapsules (1.62 grams oGanodermalucidumnā lāʻau lapaʻau maʻemaʻe i kēlā lā i kēia lā) ma ke ʻano he adjuvant i ka lāʻau antiviral lāʻau lapaʻau lamivudine ma kahi makahiki hoʻokahi i ʻike i ka hoʻomaikaʻi ʻana i ka hana ate a hoʻonui i ka pono antiviral i kahi manawa pōkole.

Ua hōʻoia ʻia kahi hōʻike lapaʻau i paʻi ʻia e Jiangyin People's Hospital ma Jiangsu Province i ka lawe ʻana i 6Ganodermalucidumnā capsules (loaʻa ka nui o 9 grams o ka mea maoliGanodermalucidum) i kēlā me kēia lā no 1-2 mau mahina he ʻoi aku ka maikaʻi o ka hopena therapeutic ma ka hepatitis B ma mua o ka lāʻau lapaʻau Kina maʻamau ʻo Minor Bupleurum Decoction granules, me ka nui o ka hoʻomaikaʻi ʻana i nā hōʻailona kumuhana, nā kuhikuhi kūpono, a me ka helu o nā maʻi maʻi i loko o ke kinoGanodermalucidumhui.

No ke ahaGanodermalucidumpono no ka ma'i hepatitis?

Ma kāna puke "Lingzhi Mai ka Mystery i ka ʻEpekema", ua ʻōlelo ʻo Polofesa Lin Zhibin i nā triterpenoids i unuhi ʻia mai kaGanodermalucidumʻO ke kino hua he mea nui ia no ka pale ʻana i ka ate.Mālama lākou i ka ʻeha o ka ate kemika i hoʻokumu ʻia e CCl4 a me D-galactosamine a me ka hōʻeha ʻana o ke akepaʻa i hana ʻia e Bacillus Calmette-Guérin (BCG) a me lipopolysaccharide.Laulaha,Ganodermalucidumloaʻa i kāna ʻano ponoʻī e pale ai i ke ake.

ʻO ke ala hope loa e hakakā ai i nā maʻi maʻi ʻo ka mālama ʻana i kahi ʻōnaehana pale ikaika.Ma waho aʻe o ka lāʻau lapaʻau a me ka hoʻokele olakino olakino, hoʻohuiGanodermalucidumi kāu meaʻai hiki ke kōkua i ka mālama ʻana i kou pale ʻana i kahi kiʻekiʻe.Hiki i kēia ke hōʻemi i ka paʻakikī o ka maʻi, e hoʻohuli i nā hihia koʻikoʻi i nā hihia maʻalahi a me nā hihia maʻalahi i nā hihia asymptomatic, i ka hopena e alakaʻi i ke olakino maikaʻi.

Kuhikuhi:

Wu, Tingyao.(2021, Iulai 28).ʻO ka wikiwiki o ka hakakā ʻana i nā maʻi hepatitis a me COVID-19 ua like ia, aGanoderma LucidumHiki ke pāʻani i kahi kuleana ma nā mea ʻelua.

Wu, Tingyao.(2020, Nowemapa 24).ʻEkolu Haʻawina Hou e pili ana i nā hopena pale oGanoderma Lucidumma ke ake: E hoemi ana i ka ma'i hepatitis Fulminant a me ka poino o ke ake i hookomoia e Formaldehyde a me Carbon Tetrachloride.